National Institute of Allergy & Infectious Diseases: Experimental COVID-19 Vaccine Protects Upper and Lower Airways in Nonhuman Primates
July 29, 2020
July 29, 2020
WASHINGTON, July 29 -- The U.S. Department of Health and Human Services' National Institute of Allergy and Infectious Diseases issued the following news release on July 28:
Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases . . .
Two doses of an experimental vaccine to prevent coronavirus disease 2019 (COVID-19) induced robust immune responses and rapidly controlled the coronavirus in the upper and lower airways of rhesus macaques exposed to SARS-CoV-2, report scientists from the National Institute of Allergy and Infectious Diseases . . .